Global Prostate Stents Market Report and Forecast 2025-2034

Global Prostate Stents Market Outlook

The global prostate stents market is expected to grow at a CAGR of 5.5% during the period 2025-2034.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Prostate Stents Market Likely to be Driven by Demand for Effective Treatment for Prostate Disorders

The global prostate stents market is likely to be driven by the rising number of cases associated with prostate related ailments and disorders. Some common problems include prostatitis (inflammation, usually caused by bacteria), enlarged prostate (BPH) or benign prostatic hyperplasia, and prostate cancer (a common form of cancer that responds positively to treatment if detected early).  BPH is a very common ailment in older men and the leading cause of lower urinary tract symptoms (LUTS). The occurrence of BPH increases after the age of 40.

Prostate stent is an alternative for certain patients who are considered unsuitable for transurethral resection of the prostate (TUR-P). Transurethral resection of the prostate is considered the gold standard for treating severe lower urinary tract symptoms (LUTS) or urine retention. Significant co-morbidity renders a few patients unfit for surgery; such patients require alternative treatment. Intraprostatic stents are an example of minimally invasive treatment for LUTS. A prostatic stent is a small device placed to open up the urethra and improve urine flow and emptying of the bladder. Stents are used widely in endoscopic urological processes.

Advanced Solutions Offered by Companies Expected to Stimulate the Market

Several companies are engaged in providing effective solutions for prostate related disorders. In 2016, SRS Medical Systems announced that the company secured CE Mark approval in the European Union for its Spanner temporary prostatic stent, devised to be used as an indwelling Foley catheter as well as an intermittent urinary catheter in male patients. According to the company, the Spanner device was composed of a pair of anchors and a silicone tube, and was devised to decrease resistance in the bladder neck and prostatic urethra without stenting the external sphincter. The blind, anaesthesia-free implantation procedure was like that of a Foley catheter.

In 2021, Olympus acquired partner Medi-Tate and its minimally invasive prostate device, iTind. The nitinol iTind device functions like a large stent; it is temporarily placed in the urinary tract using a catheter where it expands to help alleviate symptoms caused by an enlarged prostate, like loss of bladder control. The device helps in reshaping the channel to enhance urine flow, and is removed after five to seven days.

Allium Medical has introduced many types of stents for the treatment of various types of urinary tract strictures, on the basis of anatomic location. The stents are all manufactured of nitinol and have a co-polymer coating to prevent encrustations. These stents come in various shapes, are designed particularly to treat individual type of stricture, have a large calibre and a strong radial force, and are self-expandable. The unravelling feature of these Allium-made stents enables ease of removal. Some examples of such stents include the Bulbar Urethral Stent (BUS) for treatment of bulbar urethral strictures; the Triangular Prostatic Stent (TPS) for the treatment of prostate obstruction in individuals not fit or not willing to undergo a surgical procedure; the Round Posterior Stent (RPS) for the treatment of post radical prostatectomy bladder neck contracture; and the Ureteral Stent (URS) (round shaped, available in varying lengths and with an anchor option) for the treatment of ureteral strictures.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Prostate Stents Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By product, the market is segmented into:

• Permanent
• Temporary

By material, the market is classified into:

• Metal
• Plastic
• Others

By end-user the market is divided into:

• Hospitals
• Specialty Clinics 
• Research and Academic Institutes
• Others

By region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Key Industry Players in the Global Prostate Stents Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Olympus Corporation 
• SRS Medical
• Allium Medical
• Becton, Dickinson and Company
• Med pro Medical B.V.
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report